Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems
- 5 March 1987
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 74 (3), 343-347
- https://doi.org/10.1016/0304-3940(87)90321-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous antiopioid substrates?Neuropeptides, 1985
- Cholecystokinin in the central nervous system: A minireviewNeuropeptides, 1983
- Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate AnalgesiaScience, 1983
- Dopamine modulates cholecystokinin release in neostriatumNature, 1983
- Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the ratEuropean Journal of Pharmacology, 1982
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980
- Peptidergic neuronesNature, 1980
- Neuroleptic activity of the neuropeptide β-LPH62–77 ([Des-Tyr1]γ-endorphin; DTγE)European Journal of Pharmacology, 1978
- Immunochemical evidence of cholecystokinin-like peptides in brainNature, 1976
- Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activityEuropean Journal of Pharmacology, 1976